PURINETHOL

Product NDC
60763-601
11-digit product format
607630601
Labeler code
60763
Product ID
60763-601_d30b240f-cd7f-e34b-e053-2995a90ac5a8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Mercaptopurine
Dosage form
TABLET
Route
ORAL
Labeler
Stason Pharmaceuticals, Inc.
Application
NDA009053
Marketing category
NDA
Marketing start
2022-01-15
Marketing end
0000-00-00
Substance
MERCAPTOPURINE
Active strength
50 mg/1
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
60763-601-132024-01-03C16284748780-1f386c649-d44c-0266-e053-dadaa90a7c1abfb03539-907f-4424-9c88-6a03ed9467e6
60763-601-132023-01-30C16284748780-1f386c649-d44c-0266-e053-dadaa90a7c1abfb03539-907f-4424-9c88-6a03ed9467e6

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
60763-601-136076306011325 TABLET in 1 BOTTLE, PLASTIC (60763-601-13) 25 tablet2021-01-150000-00-00NoNoCurrent